Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_2026
http://purl.obolibrary.org/obo/dinto_2026
|
|---|---|
| Preferred Name | long-chain-fatty-acid--coa ligase 4 |
| Synonyms |
ec 6.2.1.3
lacs 4
long-chain acyl-coa synthetase 4
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | long-chain-fatty-acid--coa ligase 4
|
|---|---|
| label | long-chain-fatty-acid--coa ligase 4
|
| is induced by | |
| Definition | Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses arachidonate and eicosapentaenoate as substrates
|
| type | |
| is inhibited by | |
| Synonym |
ec 6.2.1.3
lacs 4
long-chain acyl-coa synthetase 4
|
| OrganismClass | human
|
| xref |
DrugBank:1457
UniProt ID:O60488
|
| definition source | DrugBank Database
|
| prefixIRI | obo2:dinto_2026
|
| Gene | acsl4
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |